EUROFARMA LAB LTDA has a total of 14 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Brazil, Mexico and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are KUNMING PHARMACEUTICAL CORP, CHAMAELEO PHARMA BVBA and EYE THERAPIES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 6 | |
#2 | Mexico | 2 | |
#3 | Canada | 1 | |
#4 | Colombia | 1 | |
#5 | Ecuador | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Uruguay | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Nita Marcelo Eidi | 5 |
#2 | Mora Ticiana Camila | 5 |
#3 | Lucinda Ruth Meri | 5 |
#4 | Picolli Carlos | 5 |
#5 | Spricigo Rodrigo | 5 |
#6 | Filho Valdir Cechinel | 4 |
#7 | Bresolim Tania Mari Belle | 4 |
#8 | Billi Maurizio | 4 |
#9 | Pedreira Marcello Creado | 4 |
#10 | Bittencourt Christiane Meire Da Silva | 4 |
Publication | Filing date | Title |
---|---|---|
BRPI1104153A2 | Ready-to-use electrolyte formulation, ready-to-use pouch, kit, uses and method of treating renal failure | |
BRPI1104180A2 | veterinary compositions for waste disposal, use, kit, and method of treating parasitic diseases | |
BRPI1103782A2 | veterinary mastitis treatment product, anti-inflammatory anti-inflammatory composition, kit, preparation method use and mastitis treatment method | |
BRPI1103205A2 | Oral pharmaceutical composition and use of oral pharmaceutical composition | |
CA2703652A1 | A standardized plant extract, process for obtaining the same and uses thereof | |
MX2009008108A | Pharmaceutical composition comprising tramadol and ketoprofen. | |
BRPI0604478A | solid composition, process of preparing the solid composition and using the composition | |
BR9802893A | Use of amantadine to treat hepatitis c. |